NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

Treatment with Verzenio plus endocrine therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to endocrine therapy alone In the seven-year landmark analysis of monarchE, treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit Results reinforce two years of Verzenio plus endocrine therapy as the standard of care in HR+, HER2-, node-positive, early breast cancer at a high risk of recurrence INDIANAPOLIS , Aug. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the primary overall survival (OS) analysis of the Phase 3 …

MANAUS, Brazil, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Brazil Potash Corp. ("Brazil Potash" or the "Company") (NYSE-American: GRO) a mineral exploration and development company with a critical mineral potash agriculture project, the Autazes Potash Project, today announced that CEO Matt Simpson, Raphael Bloise, Interim President of Potássio do Brasil and Advisory Board Director, Con Steers, have been formally invited by Mura Indigenous Council - CIM to participate in the annual Mura Indigenous Cultural Festival (FECIM) on August 29 and 30th, 2025.

Crude oil slips below the 200-day MA as bearish technicals and rising Russian exports weigh on the oil outlook ahead of key EIA inventory data.

Entravision's adtech business continues to grow in terms of revenue and profitability. At the same time, a likely-forthcoming de-regulation/M&A wave in broadcasting suggests the value of EVC's television and radio stations continues to rise. Even after the stock's recent run-up, the breakup value of EVC is around 31% above the stock's current trading price.

Realty Income remains a top pick for income-focused investors, benefiting from stable triple-net leases and a strong A- credit rating. Q2 results exceeded revenue expectations, with high occupancy and increased guidance, while European expansion supports long-term growth. Valuation is attractive given potential interest rate cuts, which could boost asset values and lower financing costs, enhancing AFFO and FFO.

SUNNYVALE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN ), the AI knowledge platform for service, will announce its fiscal 2025 fourth quarter and full year financial results after the close of regular market trading on Thursday, September 4, 2025, followed by an investor conference call and webcast at 2:00 p.m. Pacific Time (5:00 p.m. ET). Chief Executive Officer Ashu Roy and Chief Financial Officer Eric Smit will host the call and webcast.

The AI-Powered Trimble Freight Marketplace connects shippers, carriers and brokers to automate the bidding process WESTMINSTER, Colo. , Aug. 27, 2025 /PRNewswire/ -- TrimbleⓇ (Nasdaq: TRMB) welcomes Procter & Gamble (P&G) as the company's first Trimble Freight Marketplace shipper in North America.

BEIJING , Aug. 27, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered into a strategic cooperation agreement with Singapore-based BICC Pte Ltd to jointly promote the implementation and redemption of "on-chain cell assets" across multiple institutions and scenarios. This collaboration marks a new phase of "cross-enterprise redeemability" for cell assets on the blockchain, advancing the RWA ecosystem from "technical on-chain integration" to "real-world application.

AKRON, Ohio--(BUSINESS WIRE)---- $BW--B&W's Board of Directors has authorized the repurchase of outstanding 8.125% Senior Notes due 2026 and 6.50% Senior Notes due 2026.

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences: Cantor Global Healthcare Conference – New York, NY: Fireside chat at 1:35 PM EST on September 3, 2025 Morgan Stanley 23rd Annual Global Healthcare Conference – New York, NY: Fireside chat at 10:45 AM EST on September.

I maintain my Hold rating on Greenlight Capital Re, due to historically weak reinsurance and long-term investment performance, justifying its valuation discount. Recent $5 million share repurchase at $13.99 per share signals management sees the stock as undervalued and is returning capital to shareholders. Q2 2025 results showed solid underwriting gains, with a 95% combined ratio, offsetting investment losses and demonstrating improved operational performance.

While shares of Chinese electric vehicle maker Nio (NYSE: NIO) are rallying, Wall Street remains unconvinced about the company's long-term outlook.

Canadian Natural Resources offers strong long-term growth potential through diversified global operations and a focus on liquids production. The firm is investing $6.05B in capital projects this year, targeting increased output and further diversification, especially in the Alberta-region. With a track record of 9% annual production growth since FY 2021, Canadian Natural Resources is a top growth play. The energy firm projects accelerating production growth in FY 2025.

I see IREN as a high-upside, favorable risk/reward play in AI and HPC, similar to early SuperMicro, with >100% upside potential. IREN's unique advantages—massive low-cost power contracts, strong cash flow from BTC mining, and operational flexibility—give it leverage over even the best neo-cloud companies like CRWV and NBIS. Despite a technical knowledge gap, IREN's profitability and power advantage should allow it to close the competency gap and achieve a much higher valuation.

Despite pipeline setbacks and slow CASGEVY rollout, future revenue acceleration and expansion into cardiovascular and autoimmune diseases offer significant long-term growth opportunities. The company boasts a strong balance sheet with a 24-month cash runway, reducing financial risk compared to peers in a challenging biotech funding environment. Risks remain high due to clinical trial uncertainties, competition, and pre-revenue status, but a successful CASGEVY launch could change investor sentiment about the company.

Whenever Jim Cramer speaks positively about a higher-yielding dividend stock, passive income-hungry retirees should be ready to listen up and maybe even add the name to their watchlists.

Chinese offshore oil and gas major CNOOC posted a 13% decline in interim net income after lower oil prices offset the impact of record-high oil and gas production.

SALT LAKE CITY & MINNEAPOLIS--(BUSINESS WIRE)-- #Agility--Franklin Covey Co. (NYSE: FC), the premier organizational performance partner of choice, today announced that it has been recognized by Training magazine for a 5th year consecutively as a 2025 Training Magazine Network Choice Awards Winner in the Leadership Development Category. The Choice Awards is the industry's only crowd-sourced solution provider awards program. “We are deeply honored to be recognized for the fifth consecutive year by the Train.

Dollar General (NYSE: DG) is set to announce its fiscal Q2 earnings on Thursday, August 28, 2025, with analysts anticipating an EPS of $1.57 and revenue of $10.68 billion. This suggests an 8% year-over-year decrease in earnings, while projecting a 5% increase in sales, compared to the previous year's EPS of $1.70 and revenue of $10.21 billion.